Insider trades
Nicole LaBrosse, CFO of Halozyme Therapeutics HALO, has filed 0 purchases and 10 sales on the open market. The latest trade was on 02/23.
Nicole LaBrosse
SVP, CFO
- Company
- Halozyme Therapeutics HALO
- First filing
- 23/02/17
- Trades
- 89 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- No record
- Last trade
- 02/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
HALO | Open-market sale10b5-1 plan | 25/09/22 | 25/09/23 | 2,227 sh2 trades | $77.95avg. | $173,591.17 | −9.2% |
HALO | Open-market sale10b5-1 plan | 25/09/10 | 25/09/11 | 20,000 sh2 trades | $75.71avg. | $1,514,273.6 | −45.1% |
HALO | Open-market sale10b5-1 plan | 24/07/22 | 24/07/23 | 5,000 sh2 trades | $53.93avg. | $269,646.8 | −24.4% |
HALO | Open-market sale10b5-1 plan | 24/06/26–24/06/28 | 24/06/28 | 30,000 sh3 trades | $51.93avg. | $1,557,900 | −66.0% |
| Open-market sale | 23/02/16 | 23/02/21 | 2,525 sh | $49.26 | $124,381.5 | −21.8% |